Table 2

Participants meeting optimal-care goals: cardiovascular risk parameters, medication use, and monthly cost at baseline and 1 year

BaselineP valueYear 1P value
ILIDSEILIDSE
n (% of total cohort)269 (11)239 (10)0.93517 (24)359 (16)<0.0001
Diabetes
    A1C (%)6.3 ± 0.46.3 ± 0.50.926.1 ± 0.56.3 ± 0.4<0.0001
    Number of prescribed medications1.3 ± 0.91.4 ± 0.90.281.1 ± 0.51.5 ± 0.9<0.001
    Monthly cost ($)74 (33)86 (33)0.1370 (33)101 (55)<0.001
Hypertension
    Systolic blood pressure (mmHg)114 ± 10115 ± 100.68112 ± 10114 ± 10<0.0001
    Diastolic blood pressure (mmHg)65 ± 865 ± 80.9063 ± 864 ± 80.20
    Number of prescribed medications1.4 ± 1.11.3 ± 1.10.341.4 ± 1.11.5 ± 1.10.05
    Monthly cost ($)40 (24)35 (24)0.3937 (24)40 (24)0.08
Hyperlipidemia
    LDL cholesterol (mg/dl)80 ± 1581 ± 140.4980 ± 1579 ± 140.84
    HDL cholesterol (mg/dl)43 ± 1243 ± 120.9947 ± 1345 ± 12<0.0001
    Triglycerides (mg/dl)183 ± 116180 ± 1180.40152 ± 93166 ± 95<0.0001
    Non-HDL cholesterol (mg/dl)114 ± 24117 ± 240.26107 ± 23110 ± 210.03
    Number of prescribed medications1.4 ± 1.11.3 ± 1.10.481.4 ± 1.11.5 ± 1.10.009
    Monthly cost ($)48 (65)52 (65)0.6247 (65)54 (65)0.008
Total medications
    Number of prescribed medications3.4 ± 1.83.5 ± 1.70.863.2 ± 1.73.8 ± 1.6<0.001
    Monthly cost ($)163 (139)172 (142)0.86154 (128)194 (177)<0.001
  • Data are mean ± SD or frequency (%) and monthly cost data are mean (median), unless otherwise specified. Participants at optimal care defined as participants with A1C <7%, blood pressure <130/80 mmHg, and LDL cholesterol <100 mg/dl as measured at the applicable study visit.